Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients

1 year ago 29

For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.

1. Homepage
2. category-label-
3. Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients